Chapter 18 Flashcards
What are the serum measurements for hepatocyte integrity
Aspartate aminotransferase (AST)
Alanine aminotransferase (ALT)
Lactate dehydrogenase (LdH0
What are the tests that look for biliary excretory function
Serum bilirubin
Ruin bilirubin
Serum bile acids
What are the tests that look for damage to the bile canaliculus
Serum alkaline phosphatase
Serum gamma-glutamic transpeptidase (GGT)
What are the tests that look for hepatocyte synthetic function
Serum albumin
Coagulation factors, PT, PTT, fibrinogen, prothrombin, factors V, VII, IX, and X
Hepatocyte metabolism: serum ammonia aminopyrine breath test (hepatic demethylation
Reversible changes in hepatocytes
Steatosis
Cholestasis
What is steatosis
Accumulation of bilirubin in the liver
Cholestasis
Accumulation of bilirubin in the liver
How does hepatocyte necrosis occur
Fluid flows into the cell, the cell swells, and ruptures (lysis) when osmotic regulation is interrupted
Bless also form to carry off intracellular stuff to the extracellular
Macrophages cluster at these sites of injury
Predominate mode of death in ischemic/hypoxic injury
Significant part of the response to oxidative stress
Hepatocyte apoptosis
Hepatocyte shrinkage, nuclear chromatin condensation(pkynosis), fragmentation (karyorrhexis) and cellular fragmentation into acidophilus apoptotic bodies
AKA
Acidophil bodies: apoptotic hepatocytes so named due to their deeply eosinophilic stain
-COUNCILMAN BODIES: YELLOW FEVER(SAME THIN, HISTORICAL TERM)
CONFLUENT NECROSIS INT HE LIVER
WIDESPREAD PARENCHYMAL LOSS; SEVERE, ZONAL LOSS OF HEPATOCYTES
MAY BEGIN AS A ZONE OF HEPATOCYTE DROPOUT AROUND THE CENTRAL VEIN
PRODUCE A SPACE FILLED WITH CELLULAR DEBRIS, MACROPHAGES, AND REMNANTS OF THE RETICULAR MESHWORK
SEEN IN ACUTE TOXIC INJURY, ISCHEMIC INJURIES OR VIRAL/AUTOIMMUNE HEPATITIS
Bridging necrosis in the liver
This zone links central veins to portal tracts or bridges portal tracts
Vascular insult leads to parenchymal extinction due to large areas of contiguous hepatocyte death
Collapse of supporting framework can occur
Cirrhosis may result
Regeneration in the liver
Mitosis replication adjacent to those that have died, even when there is significant confluent necrosis
Stem cell like: hepatocytes an replicate even in the setting of chronic injury
-stem cell replenishment is not a significant part of parenchymal repair
Severe forms of acute liver failure activates the primary intrahepatic stem cell niche (canal of hearing)
-contribution unclear
Ductal reactions : when hepatocytes in patients with chronic disease reach replication senescence and clear evidence of stem cell activation appears
Scar deposition in the liver
Principle cell type involved in scar deposition is the fat containing, myofibroblastic hepatic stellate cell
Quiescent form:stores lipid and vitamin A (fat soluble)
Injury: activated and converted to highly fibronectin myofibroblasts
- cytokines released by Kupfer cells and lymphocytes: TGFB, MMP-2 (metaloproteinase-2), and TIMP-1 and 2 (tissue inhibitors of metalloproteinases 1 and 2).
- contraction stimulated by endothelin1
Is scar deposition in liver reversible
If the injurious agent is eliminated
Fibrous septa development in the liver
Collapse of reticular where large swaths of hepatocytes have disappeared and stellate cells are activated
Regenerating hepatocytes become surrounded in late chronic disease leads to diffuse scarring (cirrhosis
Hepatic failure
Hepatic failure ensures when 80-90% of the functional capacity of the liver is lost
80% mortality without transplant
May be due to acute injury, chronic progressive injury, or acute on chronic injury
What is acute hepatic failure
Occurs within 26 weeks (6 months) of initial injury
Absence of preexisting liver disease
Associated with encephalopathy and coagulopathy
Causes of acute hepatic failure
-massive hepatic necrosis, a result of drugs/toxins
Acetaminophen (50% onset within one week) hepatitis A, autoimmune hepatitis
Hepatitis B
Hepatitis C, cryptogenic
Drugs/toxins, hepatitis D
Hepatitis E, esoteric causes (wilson disease, buds-chiaroscuro)
Fatty change of the microvesicular type (fatty liver of pregnancy, valproate, tetracycline, Reye’s syndrome)
Morphology acute hepatic failure
-massive hepatic necrosis leads to broad regions of parenchymal loss surrounding areas of regenerating hepatocytes
Small shrunken liver
Early scarring may occur in weeks-moths
Diffuse microvesicular steatosis: diffuse poisoning of liver cells without obvious cell death and parenchymal collapse; related to fatty liver of pregnancy or idiosyncratic reactions to toxins
What does a patient initially present with with acute hepatic failure
Nausea, vomiting, and jaundice which progresses to a life threatening encephalopathy and coagulation defects
Patients with acute hepatic failure and liver transaminases
Moderate increase
Why do people with acute hepatic failure gethepatomegalt
Hepatocyte swelling, infiltrates and edema initially
Eventually there is a shrunken liver as the parenchyma is destroyed
Decline in serum transaminases is an indication of fewer viable hepatocytes ,not recovery
Prognosis acute hepatic failure
Poor prognosis
Decrease in liver enzymes, indicating few remaining hepatocytes, confirmed with worsening jaundice, coagulopathy and encephalopathy
Sequelae acute hepatic failure
Jaundice and icterus: yellowing of skin , sclera and mucus membranes
Cholestasis: systemic retention of not only bilirubin but also other solutes eliminated in bile which increases the risk of life threatening bacterial infection
Hepatic encephalopathy: due to increased serum ammonia that ranges from subtle behavioral abnormalities to marked confusion and stupor to deep coma and death
- rigidity and hyperreflexia
- asterixix is a characteristic sign
Coagulopathy: impaired clotting due to lack of production of vitamin K dependent (II, VII, IX, and X) and independent clotting factors
- easy bruising-early sign
- can lead to intracranial bleeding->herniation->death
Disseminated intravascular coagulation-liver is responsible for removing activated coagulationfrom the circulation
Portal hypertension:intrahepatic obstruction most likely; leads to ascites and hepatic encephalopathy
Hepatorenal syndrome: form of renal failure in individuals with liver failure in whom their kidneys are morphologically and functionally normal
- na retention , impaired free water excretion, decreased renal perfusion, and decreased glomerular infiltration rate
- decreased renal perfusion pressure due to systemic vasodilation, activation of renal sympathectomy nervous system (afferent arteriole vasoconstriction), increased RAAS activation->decrease GFR
- onset-hypo-nutria, elevated BUN creatinine
Asterixis
Characteristic sign of acute hepatic failure
Nonrhythmic, rapid extension flexion of the head and extremities
Seen with arms in extension and dorsiflexied wrists
Chronic liver failure
Associated with cirrhosis though not mutually exclusive
Chronic hepatitis B and C, non alcoholic fatty liver disease, alcoholic fatty liver disease
The ultimate cause of death in chronic liver failure is the same as in __ ___ ___
Acute liver failure
Ultimate cause of death from acute and chronic liver failure
Hepatic encephalopathy
Bleeding from esophageal varices
Bacterial infections
Cirrhosis
Diffuse transformation of the entire liver into regenerative parenchymal nodules surrounded by fibrous bands and variable degrees of vascular (portosystemic) shunting
No single cirrhosis, but rather multiple variable cirrhosis
Cirrhosis is no longer considered end stage liver disease because the fibrosis is potentially reversible with increasing numbers of effective treatments for cirrhosis causing conditions
Child Pugh classification of cirrhoissi
Helps monitor the decline of the patients ont he path to chronic liver failure
Class A (child Pugh)
Well compensated
Class B (child Pugh)
Partially compensated
Class C (child Pugh
Decompensated
What does stem cell activation in liver cirrhosis cause
Ductular reactions which increase with advancing stage of disease and are usually most prominent in cirrhoisis
Portal HTN cirrhosis decreased incidence morphology
Biopsy specimens with narrow, densely compacted fibrous septa separated by areas of intact hepatic parenchyma
Portal HTN increased incidence with liver cirrhosis
Broad bands of dense scar with dilated lymphatic space, less parenchyma; more likely to progress and lead to end stage disease
Clinical signs of cirrhosis before it becomes end stage
Only seen in 40% of patients
Jaundice+pruritis
Hypoalbuminemia->systemic edema
Hyperammonemia
Factor hepaticus:mercaptan formation
Males hyper-estrogenemia due to impaired metabolism can lead to palmar erythema, spider angiopathy, hypogonadism, and gynecomastia
Increased risk of developing hepatocellular carcinoma
Prehepatic causes of portal HTN
Obstructive thrombosis
Narrowing of the portal vein before entering the liver
Massive splenomegaly with increased splenic blood flow
Posthepatic causes of portal HTN
Severe right heart failure
Constrictive pericarditis
Hepatic vein outflow obstruction
Intrahepatic causes portal HTN
Usually due to cirrhosis
Schistomiasis
Massive fatty change
Diffuse fibrosis granulomatous disease such as sarcoidosis
Diseases effecting the portal microcirculation such as nodular regenerative hyperplasia
Increased resistance to portal flow
Increased portal venous flow due to hyper dynamic circulation
What is the most common cause of portal HTN
Cirrhosis
What causes increased resistance to portal flow
Contraction of vascular smooth muscle and myofibroblasts
Decreased NO production
Increased endothelin1, angiotensinogen, eicosanoids production
Disruption of blood flow by scarring and formation and parenchymal nodules
Remodeling and anastomoses impose arterial pressure on a normally low pressure system
Interferes with metabolic exchange of sinusoidal blood and hepatocytes
What causes increased portal venous flow due to hyper dynamic circulation
Splanchnic arterial vasodilation-increased efflux into the portal venous system
Due to NO, prostacyclin and TNF
Clinical portal HTN
Ascites
Portosystemic shunt formation
Congestive splenomegaly
Hepatic encephalopathy
Ascites
Excessive fluid in the peritoneal cavity
Detectable with accumulation of 500 ml
85% of ascites is due to __ __
Cirrhosis
85% of ascites is due to__
Cirrhosis
What happens with long standing ascites
Seepage of peritoneal fluid through trans-diaphragmatic lymphatic channels—>hydro-thorax, espicially onthe RIGHT
Composition of ascites
Fluid is serous, <3mg/dl of protein (albumin)
Neutrophils: suggests infection
Blood:suggests disseminated intraabdominal cancer
What leads to ascites
Sinusoidal HTN
Precolation of hepatic lymph in peritoneal cavity
Splanchnic vasodilation
Mechanism of sinusoidal ascites
Hepatic sinusoidal HTN drives fluid into the space of disse which is drained by lymphatics
Promoted by hypoalbuminemia->peripheral edema
What is the space of disse
Beneath the endothelial cells
What is found in the space of disse
Fat containing myofibroblastic hepatic stellate cells are found in the space of disse
Mechanism of ascites: percolation of hepatic lymph in peritoneal cavity
Normal flow is 800-1000ml; increased to 20L
The thoracic duct isn’t ably to keep up and fluid leaks out->peripheral interstitial edema
Mechanism of ascites: splanchnic vasodilation
Causes systemic hypotension which leads to vasoconstriction
RAAS activation leads to Na retention (and H2O follows)
Increased perfusion pressure of the interstitial capillaries
-transudation(protein poor) into the abdominal cavity
Portosystemic shunts
Flow is reversed from the portal into the systemic circulation where there are shared capillary bed
Esophageal varices: 40% of patients with advanced cirrhosis; rupture can cause massive hematemesis with 30% mortality
Falciform ligament and caput Medusa: dilated subcutaneous veins extend from umbilicus to rib margins
Rectum: hemorrhoids
Splenomegaly
Due to long standing congestion
Can cause thrombocytopenia(or pancytopenia
Due to long standing congestion
Can cause thrombocytopenia (or pancytopenia due to hypersplenism)
Hepatopulmonary syndrome
Hypoxia+dyspnea due to Ventillation/perfusion (V/Q) mismatch from rapid blood through dilated vessels with decreased time for diffusion
What exacerbates hepatopulmonary syndrome
Upright position due to gravity
What improves hepatopulmonary syndrome
Recumbent position
PortopulmonaryHTN
Dyspnea on excretion and clubbing
Pulmonary arterial HTN in liver disease and portal HTN
Excessive pulmonary vasoconstriction and vascular remodeling with concomitant portal hypertension
Acute on chronic liver failure
Individuals with stable, well-compensated chronic liver disease develop sudden signs of acute liver failure
Commonly have established cirrhosis and extensive vascular shunting
Significant amounts of parenchyma have borderline vascular supply and are vulnerable to superimposed insult
Short term mortality of acute on liver failure
50%
Hepatic A virus
Benign, self limited disease
Does not cause chronic hepatitis or a carrier state
Rarely lethal
Transmission hepatitis A
Fecal oral via contaminated water
Raw or steamed shellfish that get it from human sewage contaminated seawater
Donated blood atrisk for HAV
No rare
What kind of virus is HAV
Single stranded + RNA
Anti-HAV immunoglobulin Ig_ are seen in the serum with onset of HAV—implies acute infection
M
In HAV infection as Ig_ declines, Ig_ appears implying memory
M G
After HAV infection Ig_ persistence for years conferring long term immunity
G
Clinical HAV
Mild or asymptomatic and rare after childhood
Hepatitis B
Infection that has a predilection for the liver and can cause a wide spectrum of disease manifestations , with most of the cases leading to asymptomatic chronic disease or clearance
5 different forms of HBV induced illness
Acute hepatitis with recovery and clearance of virus
Non-progressive chronic hepatitis
Progressive chronic disease ending in cirrhosis
Acute hepatic failure with massive liver necrosis
Asymptomatic, ‘healthy’ carrier state
Chronically is an important precursor for hepatocelullar carcinoma
Transmission hepatitis b
High prevalence ares (AFrica, Asia): childbirth
Intermediate prevalence: horizontal (breaks in skin/mucus membranes in children with close body contact)
Low prevalence: unprotected sex, IV drug use
HBV viral characteristics
Partially dsDNA virus
Mature virus=spherical double layered “Dane particle” with outer surfac protein+lipid envelope around an electron dense slightly hexagonal core
Serum markers for HBV
HBsAg
Anti-HBs
HBeAg, HBV-DNA and DNA polymerase
Anti-HBc
HBsAg
Appears before the symptoms, peaks during the overt disease, and lasts for about 12 weeks
*donated blood is screened for HBsAg
Anti-HBs Ab
Doesn’t rise until the disease is over, about the same time that the HBaAg goes away. The IgG form is what provides the immunity
Anti-HBs may persist for _, conferring protection-basis for current vaccination strategies using non infectious HBsAg
Life
HBeEg, HBV-DNA and DNA polymerase
All appear after HBsAg and indicate there is active viral replication
___ espicially can be used to track the disease and antibodies to it indicate the disease is about to wane
HBeAg
Persistent HBeAg
Indicator of continued viral replication, infectivity, and probably progression to chronic hepatitis
Anti-HBe antibodies
Acute infection has peaked and is on the wave
Anti-HBc Ab
Appears just before the onset of symptoms and shows up with increased aminotransferase levels (liver damage)
What is the best predictor of HBV chronicicity
Age at the time of infection
Younger age-increased probability of chonicity
What is the main determinant of the outcome of HBV
Host immune response to the virus is the main determinant of the outcome of the infection
Strong response by virus specific CD4 and CD8 interferon (IFN-y)-producing cells is associated with the resolution of acute infection
HBV does not cause direct hepatocyte injury-what causes injury
CD8 cytotoxic T cells attack infected hepatocytes
Complete cure of HBV
Difficult due to viral insertion into host DNA
Limits the development of an effective immune response
Virus persists in the face of rugs that impair its replication
Goal of treatment in chronic HBV
Slow progression of disease, reduce liver damage and prevent cirrhosis and cancer
How do we prevent spread of HBV
Vaccination and screening of blood donations prevents it
Treat HBV
Most cases are self limited and resolve without treatment
What percent of HBV patients Barbour chronic disease
5-10%
Is fulminant hepatitis common
No rare
Morphology HBV*
In chronic HBV, liver biopsy shows finely granular ground glass hepatocytes packed with HBsAg
-cells with endoplasmic reticulum swollen by HBsAg-diagnostic hallmark
What is the diagnostic hallmark of HBV
Liver biopsy shows finely granular ground glass hepatocytes packed with HBsAg
-cells with endoplasmic reticulum swollen by HBsAg
Hepatitis C virus characteristics
SsRNA virus
Genomic instability+antigenic variability=no vaccine
Anti-HCV igG antibodies do not confer effective immunity and re infection is possible
Infection and clearance HCV
More mild than HBV with most acute cases being asymptomatic, but 80-90% of patients develop chronic infection and 20% get cirrhosis
Exists as closely related genetic variants inside infected patients
Clinical HCV
Characteristic repeated bouts of hepatic damage
Persistent infection and chronic hepatitis=hallmarks of HCV infection
Acute illness is generally asymptomatic chronic HCV infection==persistent elevations in serum aminotransferases
-wax and wane, but never normal
Cryoglobulinemia is found in 35% of individuals with chronic hepatitis C infection
Diagnose HCV
HCV RNA is detected in blood for 13 weeks during active infection with concurrent increase in aminotransferase levels (will see the increase in ALT/AST chronically)
What is HCV associated with
Metabolic syndrome (genotype3) Can give rise toinsulin resistance and non alcoholic fatty liver disease
Treatment HCV
Genotype 2 and 3 have best response to treatment, espicially in patients with IL-28B gene (encodes IFN-y involved in resistance to HCV) polymorphisms
-better response to IFN-a and ribavirin
Newer regimens may improve prognosis
Morphology HCV
Leads to portal lymphoid follicle, bile duct reactive changes and lobular regions of microvesicular steatosis
Bile duct injury is possible that can histologically mimic primary biliary cirrhosis (easily distinguished clinically)
Chronic HCV shows lymphoid aggregates or fully formed lymphoid follicles; fatty change of scattered hepatocytes
Hepatitis D is dependent for its life cycle on _
HBV
How is HDV dependent on HBV
External coat antigen surrounds an internal “delta antigen” the only protein produced by the virus
A vaccine for HBV also prevents __
HDV
What are the setting of HDV
Co-infection
Superinfection
How get confection HDV
HBV must become established first to provide the HBsAg necessary for development of complete HDV virions, resulting in acute hepatitis indistinguishable from acute hepatitis of HBV-only etiology
Prognosis HDV confection
Self limited
Followed by clearance of both viruses
When is there a higher rate of acute hepatitis failure with HDV coingection
In IV drug users
How detect coinfection with HDV
Best indicated by detection of IgM against both HDAg and HBcAg
Superinfection HDV
When a chronic carrier of HBV is exposed to a new inoculum of HDV get superinfection 30-50 days later
Severe acute hepatitis in a previously unrecognized HBV carrier, or exacerbation of pre existing chronic hepatitis B infection
Acute phase superinfection HDV
Active HDV replication and suppression of HBV with high transaminase levels
Chronic phase superinfection HDV
HDV replication decreases , HBV replication increases, transferase levels fluctuate, and disease progresses to cirrhosis and sometimes hepatocellular carcinoma
Lab values superinfection HDV
HBsAg present in serum, anti HDV persist for months or longer
Who gets HDV
Western countries: largely restricted to IV drug users and those who have had multiple blood transfusions
Clinical HDV
HDV RNA is detectable in the blood and liver just before and in the early days of acute symptomatic disease
Ig_ anti-HDV is the msot reliable indicator of a recent HDV exposure
M
How get HEV
Enterically transmitter, water borne infection
Zoonotic=animal resivoirs(increased risk with exposure to monkeys, cats, pigs, and dogs)
Who gets HEV
Occurs primarily in young to middle aged adults
HEV causes 30-60% of sporadic acute hepatis in ___(more than HAV)
India
Characteristic feature HEV
Higher mortality rate among pregnant women-almost 20%
Treat HEV
Self limiting
What is HEV not associated with
Chronic liver disease or persistent fire is in immunocompentent patients
In HEV virions are shed in __ during the acute illness
Stool
What type of virus i HAV
SsRNA
What type of virus is HBV
Partially dsDBA
What kind of virus is HCV
SsRNA
What type of virus in HDV
Circular defective SsRNA
What type of virus is HEV
SsRNA
What family is HAV in
Hepatovirus (picornavirus)
What family is HBV in
HepaDNAvirus
What family is HCV
Flaviviridae
What family is HDV
Subviral particle in deltavirdae family
What family is HEV
Hepevirus
Transmission HAV
Fecal-oral (contaminated H2O)
Transmission HBV
Parenteral, sexual contact, perinatal
What family is HCV
Parenteral, intranasal cocaine
Family HDV
Parenteral
Family HEV
Fecal oral
Incubation HAV
2-6 weeks
HBV incubation
2-26 weeks (avg 8)
HCV incubation
4-26 weeks (avg9)
HDV incubation
2-26 weeks (avg 8)
HEV incubation
4-5 weeks
HAV progression to chronic
Never
HBV progression to chronic
5-10%
HCV progression to chronic
> 80%
HDV progression to chronic
10% coinfection
90-100% superinfection
HEV progression to chronic
Never
Diagnosis HAV
IgM antibodies
HBV diagnosis
HBsAg, antiHBcAg; PCR for DNA
HCV diagnosis
PCR for DNA, Elisa for Ab
HDV diagnosis
IgM and IgG antibodies; HDV RNA serum; HDAg in liver
Diagnosis HEV
Serum IgM and IgG; PCR for HEV RNA
Which hepatitis show fulminant
A, B, D
Which hepatitis fulminant in pregnant women
HEV
Clinicopathological syndromes of hepatitis
Acute asymptomatic infection with recovery (serologic evidence only)
Acute symptomatic hepatitis with recovery (anicteric or interic)
Chronic hepatitis
Acute liver failure
Carrier state
Acute asymptomatic infection with recovery (serologic evidence only)
Worldwide, HAV, and HBV infections are frequently subclinical events in childhood verified only in adulthood by the resented of anti-HAV or anti HBV antibodies
Acute symptomatic hepatitis with recovery (anicteric or icteris) four phases
Incubation(peak infectivity during last asymptomatic days of incubation period and early days of acute symptoms)
Symptomatic pre-icteric phase
Symptomatic interic phase
Convalescence
Chronic hepatitis
With progression to cirrhosis
Without progression to cirrhosis
Acute liver failure
With massive hepatic necrosis
With submissive hepatic necrosis
Carrier state hepatitis
“Healthy carrier’: individual with HBsAg, no HBeAg, andi HBeAg, normal aminotransferases low or undetectable serum HBV DNA, and liver biopsy showing a lack of significant infalmmation and necrosis
Inactive carrier
Not recognized in the United States
Acute hepatitis morphology
Lymphoplasmactyic (mononuclear) infiltrate
Spotty necrosis or lobular hepatitis scattered throughout a lobule
Necrosis empty cytoplasm , cell membrane ruptures leads to hepatocyte dropout
Collapsed sinusoidal collagen reticulin framework
Apoptosis; hepatocytes shrink, become eosinophilic, pyknotic, fragmented
Lack of portal inflammation
Severe acute hepatitis morphology
CONFLUENT NECROSIS of hepatocytes around central veins
Cellular debris, collapsed reticulin fibers, congestion +/- hemorrhage
Variable inflammation
Central portal BRIDGING NECROSIS leads to parenchymal collapse
Can lead to massive hepatic necrosis/acute failure
Can develop post hepatitis. Cirrhosis with abundant scarring
Chronic hepatitis morphology
Mononuclear portal infiltration
Mild: inflammatory infiltrates are limited to portal tracts
Progressive dise: extension of chronic inflammation from portal tracts with interface hepatitis
Linking of orca and portal central regions=bridging necrosis
Continued loss of hepatocytes=fibrous septum formation
Associated hepatocyte regeneration=cirrhosis
What causes toxic shock syndrome
Staphylococcus aureus
What causes typhoid fever
Salmonella typhi
What causes secondary or tertiary syphilis
Treponema pallidum
Ascending cholangitis
Acute infalammation response within the intrahepatic biliary tree due to intrabiliary bacterial microflora during a partial or complete obstruction
What is autoimmune hepatitis
Chronic, progressive hepatitis
Presence of autoantibodies
Therapeutic response to immunosuppression
What triggers autoimmune hepatitis
Viral infection, drug/toxin exposure
Patients at risk for autoimmune hepatitis
Caucasion: DRB1* alleles (HLA association)—genetic predisposition
Most frequent in white Northern Europeans
Females predominance
What are the two types of autoimmune hepatitis
2 types based on circulating antibodies
Type 1 autoimmune hepatitis
Middle aged older people
ANA (anti-nuclear), ASMA (anti-smooth msucle), ANTI-SLA/LP (anti-soluble liver antigen/liver-pancreas antigen), AMA (anti-mitochondrial) antibodies
Type 2 autoimmune hepatitis
Children and teenagers
Anti-LKM1 (anti-liver kidney microsome-1) antibodies against CYP2D6
ACL1 (anti-liver cytosolic) antibodies
Early phase of severe parenchymal destruction followed rapidly by scarring
-fibrosis take years to develop in chronic viral hepatitis, does not develop in acute hepatitis
Severe necroinfalmmatory activity indicated by interface hepatitis or parenchymal collapse
Mononuclear infiltrate: plasma cells
Hepatocyte ROSETTES in areas of activity
Early phase autoimmune hepatitis
Severe parenchymal destruction followed rapidly by scarring
Fibrosis takes years to develop in chronic viral hepatitis, does not develop in acutehepatitis
Severe necroinflammatory activity indicated by interface hepatitis or parenchymal collapse
Mononuclear infiltrate: plasma cells
Hepatocyte ROSETTES in areas of activity
Progressive or indolent automimmune hepatitis that lead to liver failure initial and chronic siding
Initial: severe hepatocyte injury with necrosis but little scarring
Chronic: burned out cirrhosis with little necroinflammatory activity; likely due to years of subclinical disease
With autoimmune hepatitis, acute onset with fulminant disease in _ weeks
8
Autoimmune hepatitis hepatic encephalopathy
Yup
What happens if autoimmune hepatitis is untreated
40% mortality in 6 months
Both type 1 and type 2 are likely to lead to liver failure
What percent of autoimmune hepatitis survivors have cirrhosisi
40%
Characteristic autoimmune hepatitis
Plasma cells are prominent and characteristic component of the inflammatory infiltrate in biopsy specimens showing autoimmune hepatitis
Prognosis autoimmune hepatitis
Between in adults than in children (delay in diagnosis in pediatric population)
Treat autoimmune hepatitis
80% of patients respond to immunosuppression for long term survival
End stage autoimmune hepatitis
Liver transplant with 75% survival at 10 years, recurrent ein 20% of patients
Drug or toxin liver damage
May be immediate or delayed
Mild to severe
Predictable (intrinsic, dose dependent) or unpredictable (idiosyncratic, multi-factorial)
Due to direct toxicity, conversion of a xenobiotic to a toxin or from immune mediated toxicity
Recovery usually occurs with removal of the offending agent
What is the most common cause of acute liver failure necessitating liver transplant in the USA
Acetaminophen
Why does acetaminophen cause liver failure
Due to toxic metabolite produced from the CYP450 breakdown in acinus zone 3 hepatocytes
What is zone 3
Closest to the terminal hepatic vein (central vein) and furthest from the portal vein
Central vein turns into the hepatic vein
Zone 2
Tries to compensate and become injured
Severe acetaminophen overdose
The zone of injury extends into zone 1 (periportal hepatocytes) and this is when you start getting acute hepatic failure
Why can alcohol or codeine make acetaminophen
Upregulate CYP450 and make things worse
Chlorpromazine and liver
Cholestasis in patients who are slow to metabolize it to an innocuous byproduct
Halothane and liver
Fatal immune mediated hepatitis in some patents exposed on multiple occasions
What are the types of liver disease caused by alcohol
Hepatocellular steatosis or fatty change
Alcoholic hepatitis
Streatofibrosis up to and including cirrhosis (only in a small fraction)
- patterns of scarring typical for all fatty liver diseases including alcohol
- cirrhosis develops in only a small fraction of chronic alcoholics
Hepatic steatosis (fatty liver)
Microvesicular lipid droplets within hepatocytes
With chronic use accumulates in microvesicular droplets which displace the nucleus
Large, soft, greasy, yellow liver
No fibrosis
Completely reversible if patients abstains from alcohol
Alcoholic (steato-) hepatitis
Hepatocyte swelling (fat, H2O, proteins)+necrosis
Mallory-denk bodies
Neutrophilic reaction to degenerating hepatocytes, espicially those with Mallory dunk bodies
Mallory desk bodies
Intracellular eosinophilic aggregates of intermediate filaments (keratin 8 and 18, ubiquitin) in ballooning hepatocytes
-hepatocytes are epithelial cells
Mallory desk bodies==damaged intermediate filaments(in hepatocytes, cytokeratin)
What are Mallory denk bodies seen in
Alcoholic hepatitis, non alcoholic fatty liver disease, wilson disease, and chronic biliary tract disease
Mallory denk bodies mean alcoholic hepatitis
Characteristic finding in alcoholic hepatitis but not specific
Alcoholic steatofibrosis
Activation of sinusoidal stellate cells+portal fibroblasts=fibrosis (fibrosis begins with sclerosis of central veins (zone3)
Scarring in a chicken wire fence pattern
Laennec cirrhosis with continuous use due to developing modularity and progressive inter webbing of the scare
Liver is large, brown, shrunken and non fatty
Closer to cirrhosis =less likely to regress
Alcoholic steatlfibrosis scarring in chicken wore fence pattern
Fibrosis spreads outward and encircles individual or small clusters of hepatocytes
Acloholic steatofibrosis laennec cirrhosis with continuous use due to developing modularity and progressive inter-webbing of the scares
Classic micro nodular cirrhosis first described for end stage alcoholic liver disease
Cirrhosis==chronic liver disease; laennec (aka micro nodular)==chicken-wire==alcoholic steatofibrosis
Large bands of fibrous tissue surrounding nodules
Risk factors for developing alcoholic cirrhosis
10-115% of alcoholics develop cirrhosis
Females are more susceptible
African American>caucasion
Iron overload, HBV, HCV=increased severity of liver disease
Mutation for alcohol intolerance
Homozygous ALDH*2 (asians) has alcohol intolerance
Flushing, nausea, lethargy
Hepatocellular steatosis pathogenesis
Impaired lipoprotein assembly and secretion
Increased peripheral catabolism of fat-> release of free fatty acids into the circulation
Shunting of substrates away from catabolism and towards lipid biosynthesis (due to increased NADH production by enzymes of metabolism)
-alcohol dehydrogenase and acetaldehyde dehydrogenase-> increased NADH production
Alcoholic hepatitis pathogenesis
Acetylaldehyde induced lipid peroxidation and protein adduct formation (carcinogen)
Induced CYP450-increases conversion of other agents to form potentially toxic metabolites
Impaired methionine metabolism
Release of bacterial endotoxin (LPS)
Release of endothelin1
Decreased perfusion of hepatic sinusoids
Effect of impaired methionine metabolism
Decreases glutathione levels that are normally protective of ROS
What happens when alcohol causes the release of bacterial endotoxin (LPS)
Pro inflammatory
Estrogen increases gut permeability to endotoxin (LPS)->increased expression of the LPS receptor (CD14, TLR4) in kupffer cells==women are more sensitized to pro inflammatory effects
Alcoholic liver disease pathogenesis
Chronic disorder of steatosis, hepatitis, progressive fibrosis and deranged perfusion
Due to an agent that was initially only marginally harmful
Clinic hepatic steatosis
Hepatomegaly
Mild increase of serum bilirubin and alkaline phosphatase levels
Severe dysfunction Is rare
Alcoholic liver disease clinical
AST:ALT>2:1
90% 5 year survival with abstinence in patients free of jaundice, ascites, or hematemesis
50-60% 5 year survival in patients that do not discontinue use
Alcoholic hepatitis clinical
Increased bilirubin, alkaline phosphatase and aserum aminotransferase
Neutrophilic leukocytosis
Nonspecific symptoms: malaise, anorexia, weight loss, abdominal discomfort
Follows a bout of heavy drinking
Treatment alcoholic hepatitis
Cessation of alcohol+adequate nutrition may slowly clear disease
Each bout of alcoholic hepatitis has a _% risk of death
10-20
If a patient with alcoholic hepatitis refrains from alcohol can they still progress to cirrhosis
Yup
_% of people with alcoholic hepatitis progress to cirrhosis without treatment
1/3
Clinical alcoholic cirrhosis
Hepatic dysfunction: increased aminotransferase, bilirubin, alkaline phosphatase, hyperproteinemia (globulins, albumin, clotting factors)
Anemia
May be clinically silent
Generally irreversible
End stage alcoholic hepatitis
Hepatic coma
Massive GI hemorrhage
Intercurrent infection(predisposed to infection)
Hepatorenal syndrome after bout with hepatitis
Hepatocellular carcinoma
What is the most common cause of chronic liver disease in the USA
Non alcoholic fatty liver disease
Non alcoholic fatty liver disease
Spectrum of disorders with hepatic steatosis
Patients consume<20g alcohol/week
80gm/day of alcohol is considered the threshold for the development of alcoholic liver disease
Risk factors for non alcoholic fatty liver disease
Increased incidence due to increased obesity and the association with metabolic syndrome
Contributes to progression of other liver disease (HBV, HCV)
Increased risk of hepatocellular carcinoma
Hispanic>african American>caucasion
Two hit model of non alcoholic fatty liver disease
Insulin resistance leads to hepatic steatosis
Hepatocellular oxidative injury leads to liver cell necrosis and inflammatory reactions
What factors can lead to hepatic steatosis, obesity, and insulin resistance
Increased high calorie food intake, high fructose corn syrup, decreased exercise, genetic predisposition
How does metabolic syndrome lead to nonalcoholic fatty liver disease
Dysfunctional adipose tissue (endocrine organ), decreased production of adiponectin, increased TNFa, IL6=hepatocyte apopotosis
Why get apoptosis with non alcoholic fatty liver disease
Oxidative damage to mitochondria and plasma membranes